ClinicalTrials.gg
Sign In

Desmoplastic Small Round Cell Tumor clinical trials

The registry lists 59 studies for Desmoplastic Small Round Cell Tumor across more than 10 countries. 14 are recruiting or about to start. 17 of them are mainly about Desmoplastic Small Round Cell Tumor (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Desmoplastic Small Round Cell Tumor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
28
Recruiting
12
Active, not recruiting
6
Terminated
6
Status unknown
2
Withdrawn
2

Phase

Phase 2
33
Phase 1
23
Early Phase 1
3
Phase 3
2

Where

United States
43
France
5
United Kingdom
5
Spain
5
Germany
4
Australia
4

Who runs them

Memorial Sloan Kettering Cancer Center (9) · National Cancer Institute (NCI) (6) · Children's Oncology Group (4) · M.D. Anderson Cancer Center (3) · Seattle Children's Hospital (2) · Mayo Clinic (2) · Societe Internationale d'Oncologie Pediatrique (2) · European Organisation for Research and Treatment of Cancer - EORTC (2)

What is being tested here

Drugs under test in Desmoplastic Small Round Cell Tumor studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
PM 01183202
Doxorubicin104
Seclidemstat102
Ifosfamide102
Trastuzumab deruxtecan101
Irinotecan101
Zoledronic Acid101
Pegylated TOP1 Inhibitor PEEL-224101
Tislelizumab101
Liposomal doxorubicin101

Drug classes tested here Alkylating agents 1 open · Tyrosine kinase inhibitors (TKIs) 5 · Angiogenesis inhibitors 3 · Antimitotic agents 3 · Antimetabolites 3

Coming up

0phase 3 studies under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 12 Desmoplastic Small Round Cell Tumor studies recruiting now, 4 (33%) set no upper age limit and 8 (67%) stop at 75 or younger. 9 (75%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
105 (42%)5 (42%)
1812 (100%)12 (100%)
3010 (83%)10 (83%)
409 (75%)9 (75%)
508 (67%)8 (67%)
656 (50%)6 (50%)
755 (42%)5 (42%)
854 (33%)4 (33%)

Across all 59 studies, recruiting or not: 53% stop at 75 or younger and 49% at 65; 78% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 59. Browse all 59 → or search them.